News Tanvex BioPharma, Inc.

Equities

6541

KYG8676P1037

End-of-day quote Taiwan S.E. Other stock markets 03:30:00 13/05/2024 am IST			5-day change	1st Jan Change
43.55 ^TWD	+1.28%		-2.57%	-33.10%

14/03	Tanvex BioPharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
06/02	Tanvex BioPharma, Inc. Announces the Appointment of James Williamson as Accounting Officer	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tanvex BioPharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	14/03	CI
Tanvex BioPharma, Inc. Announces the Appointment of James Williamson as Accounting Officer	06/02	CI
Tanvex BioPharma, Inc. Announces the Appointment of Chen, Lin-Cheng as CEO	06/02	CI
Tanvex Biologics Corporation announced that it expects to receive $5 million in funding from Tanvex BioPharma, Inc.	06/02	CI
Tanvex BioPharma USA, Inc. announced that it expects to receive $50 million in funding from Tanvex BioPharma, Inc.	06/02	CI
Tanvex BioPharma, Inc. Announces the Resignation of Ken Huang as Accounting Officer	05/01	CI
Tanvex BioPharma, Inc. Announces Change of Chairman	29/12	CI
Tanvex BioPharma, Inc. Announces Resignation of Yun Yen Chairperson and Director, Effective December 29, 2023	21/12	CI
Tanvex BioPharma, Inc. Announces Change of Corporate Governance Officer	21/12	CI
Tanvex BioPharma, Inc. Announces Resignation of Yun Yen as CEO, Effective December 29, 2023	21/12	CI
Tanvex BioPharma, Inc. Announces Resignation of Yun Yen as Chairman/President, Effective December 29, 2023	21/12	CI
Tanvex BioPharma, Inc. Announces the Resignation of Stacey Tsai as Acting Spokesperson and Corporate Governance Officer	30/11	CI
Tanvex BioPharma, Inc. Appoints Wen Chung Yeh as Chief Financial Officer	13/11	CI
Tanvex BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11	CI
Tanvex BioPharma, Inc. Announces Management Changes	01/11	CI
Tanvex BioPharma, Inc.(TWSE:6541) added to S&P Global BMI Index	18/23/18	CI
Tanvex BioPharma, Inc.(TWSE:6541) added to Taiwan TAIEX Index	07/23/07	CI
Tanvex BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	09/23/09	CI
Tanvex BioPharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15	CI
Tanvex BioPharma, Inc.(TWSE:6541) dropped from Taiwan TAIEX Index	12/23/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Tanvex BioPharma, Inc.

Equities

6541

KYG8676P1037

Summary

Filters